| ²é¿´: 884 | »Ø¸´: 3 | |||
| ±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
evebľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
SCIÊÕ¼¼°ÒýÓòéѯ
|
||
|
×÷Õß: Zhang B, Feng X, Wang J, Xu X, Lin N, Liu H. ÎÄÌâ: Combined antitumor effect of Ad-bFGF-siRNA and Ad-Vpr on the growth of xenograft glioma in nude mouse model. ÆÚ¿¯Ãû,Äê·Ý,¾í(ÆÚ),ÆðÖ¹Ò³Âë: Pathol Oncol Res. 2011 Jun;17(2):237-42. È«ÎÄÁ´½Ó: http://dx.doi.org/10.1007/s12253-010-9303-5 Êý¾Ý¿âÃû³Æ: springer ÊÕ¼ÐÅÏ¢: ÇóÖú SCI ÊÕ¼ÐÅÏ¢ ÇóÖú±»Òý´ÎÊý |
» ²ÂÄãϲ»¶
284Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
һ־Ըɽ¶«´óѧҩѧѧ˶Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
07»¯Ñ§280·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çó²ÄÁÏ£¬»·¾³×¨Òµµ÷¼Á
ÒѾÓÐ3È˻ظ´
335Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸¼ª´ó»¯Ñ§322Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
»·¾³Ñ§Ë¶288Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
341Çóµ÷¼Á(Ò»Ö¾Ô¸ºþÄÏ´óѧ070300)
ÒѾÓÐ6È˻ظ´
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658104
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.3Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
eveb: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, thank 2014-11-13 12:27:03
jssxh: LS-EPI+1, лл²ÎÓ룬Çë¼ÌÐø¹Ø×¢±¾°æ¿é 2014-11-13 14:59:39
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
eveb: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, thank 2014-11-13 12:27:03
jssxh: LS-EPI+1, лл²ÎÓ룬Çë¼ÌÐø¹Ø×¢±¾°æ¿é 2014-11-13 14:59:39
|
Combined Antitumor Effect of Ad-bFGF-siRNA and Ad-Vpr on the Growth of Xenograft Glioma in Nude Mouse Model ×÷Õß:Zhang, B (Zhang, Biao)[ 2 ] ; Feng, XQ (Feng, Xuequan)[ 3 ] ; Wang, JH (Wang, Jinhuan)[ 1 ] ; Xu, XN (Xu, Xinnu)[ 4 ] ; Lin, N (Lin, Na)[ 4 ] ; Liu, HS (Liu, Hongsheng)[ 4 ] PATHOLOGY & ONCOLOGY RESEARCH ¾í: 17 ÆÚ: 2 Ò³: 237-242 DOI: 10.1007/s12253-010-9303-5 ³ö°æÄê: JUN 2011 ²é¿´ÆÚ¿¯ÐÅÏ¢ ÕªÒª Basic fibroblast growth factor (bFGF) has been demonstrated to correlate with glioma grade and clinical outcome and has established its possible usefulness as a target for glioma therapy. Vpr has been described as an antitumor agent and displays a potent antitumor nature. Here, we try to investigate whether a combined treatment with bFGF-siRNA and Vpr gene would have a enhanced effectiveness on glioma in vitro and in vivo.After treatments with only Ad-bFGF-siRNA, only Ad-Vpr, and a combination of both, we assessed the changes in cell proliferation, cell cycle, and apoptosis in vitro by the methods of MTT, PI and FITC-AnnexinV double staining, respevtively. In addition, we also evaluated the combined effect of bFGF-siRNA and Vpr gene therapy on glioma in vivo using xenograft glioma models in nude mice. Combined Ad-bFGF-siRNA and Ad-Vpr treatment was more better successful in inhibiting cell proliferation in comparison with treatments of either Ad-bFGF-siRNA or Ad-Vpr alone. Treatment of Ad-Vpr alone or a treatment of a combination of Ad-bFGF-siRNA and Ad-Vpr induced the G2/M cell cycle arrest and apoptosis; however, combined treatment was more effective than the Ad-Vpr treatment alone. Although each single treatment can slow the growth of xenograft glioma, the combined treatment with Ad-bFGF-siRNA and Ad-Vpr was better than either the Ad-bFGF-siRNA or Ad-Vpr treatment alone. Our results suggest that the combination therapy with bFGF-siRNA and Vpr gene can achieve a enhanced activity of anti-glioma, supporting the idea that the combination of these two antitumor agents could open new perspectives in glioma therapy. ¹Ø¼ü´Ê ×÷Õ߹ؼü´Ê:siRNA; bFGF; Vpr; Adenoviral vector KeyWords Plus:IN-VIVO ELECTROPORATION; HIV-1 VPR; NUCLEAR ACCUMULATION; CELLS; GLIOBLASTOMA; INHIBITION; CASPASE-9; RECEPTOR; PLASMID; TUMORS ×÷ÕßÐÅÏ¢ ͨѶ×÷ÕßµØÖ·: Wang, JH (ͨѶ×÷Õß) Tianjin Huan Hu Hosp, Dept Neurosurg, 122 Qixiangtai Rd, Tianjin 300060, Peoples R China. µØÖ·: [ 1 ] Tianjin Huan Hu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China [ 2 ] Tianjin Huan Hu Hosp, Clin Lab, Tianjin 300060, Peoples R China [ 3 ] Tianjin First Ctr Hosp, Dept Neurosurg, Tianjin 300192, Peoples R China [ 4 ] Tianjin First Ctr Hosp, Key Lab Crit Care Med, Minist Hlth, Tianjin 300192, Peoples R China µç×ÓÓʼþµØÖ·:wangjinhuanfch@yahoo.com.cn »ù½ð×ÊÖúÖÂл »ù½ð×ÊÖú»ú¹¹ ÊÚȨºÅ National Natural Sciences Foundation of China 30672158 ²é¿´»ù½ð×ÊÖúÐÅÏ¢ ³ö°æÉÌ SPRINGER, VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS Àà±ð / ·ÖÀà Ñо¿·½Ïò:Oncology; Pathology Web of Science Àà±ð:Oncology; Pathology ÎÄÏ×ÐÅÏ¢ ÎÄÏ×ÀàÐÍ:Article ÓïÖÖ:English Èë²ØºÅ: WOS:000290587300007 PubMed ID: 20848251 ISSN: 1219-4956 ÆÚ¿¯ÐÅÏ¢ Impact Factor (Ó°ÏìÒò×Ó): Journal Citation Reports® ÆäËûÐÅÏ¢ IDS ºÅ: 763VH Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 20 Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 5 ÒýÎÄÍøÂç 5 ±»ÒýƵ´Î 20 ÒýÓõIJο¼ÎÄÏ× ²é¿´ Related Records ²é¿´ÒýÖ¤¹ØÏµÍ¼ ´´½¨ÒýÎĸú×Ù (Êý¾ÝÀ´×Ô Web of ScienceTM ºËÐĺϼ¯) È«²¿±»ÒýƵ´Î¼ÆÊý 5 / ËùÓÐÊý¾Ý¿â 5 / Web of Science ºËÐĺϼ¯ 1 / BIOSIS Citation Index 0 / Öйú¿ÆÑ§ÒýÎÄÊý¾Ý¿â 0 / Data Citation Index 0 / SciELO Citation Index ×î½üµÄÒýÎÄ Zhang, S. HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells. CLINICAL & TRANSLATIONAL ONCOLOGY, MAR 2014. ²é¿´È«²¿ ´Ë¼Ç¼À´×Ô: Web of ScienceTM ºËÐĺϼ¯ ½¨ÒéÐÞÕý Èç¹ûÏ£ÍûÌá¸ß´Ë¼Ç¼ÖÐÊý¾ÝµÄÖÊÁ¿£¬ÇëÌṩÐÞÕý½¨Òé¡£ |
2Â¥2014-11-13 12:21:57
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658104
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.3Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
3Â¥2014-11-13 12:22:08
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- LS-EPI: 1647
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658104
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.3Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
4Â¥2014-11-13 12:22:41













»Ø¸´´ËÂ¥